Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:04 PM
Ignite Modification Date:
2025-12-24 @ 12:04 PM
NCT ID:
NCT03677661
Eligibility Criteria:
Inclusion Criteria:
* Between 18 and 65 years of age;
* Sustained a mTBI in the past 3 to 12 weeks;
* Having ongoing post-concussion symptoms from the list in the PCSS that started 72 hours or less after an impact;
* Having felt at least one or more cognitive symptoms that started 72 hours or less after an impact;
* Having abnormalities on one of the following test : the cervical physical examination (eg, tenderness/spasm on segmental testing, or reduced motion), the vestibular evaluation (eg, Dix hallpike test, vestibulo-ocular reflex test, or head thrust test) or the ocular motor evaluation (eg, convergence, smooth visual pursuits, or saccades).
Exclusion Criteria:
* Patients with more than 30 minutes of loss of consciousness for the current episode;
* Patients with more than 24 hours of post-traumatic amnesia;
* Glasgow Coma Scale score lower than 14 at the time of injury;
* Patients with radiographic evidence of subdural hemorrhage, epidural hemorrhage, intraparenchymal hemorrhage, and cerebral or cerebellar contusion;
* Post-injury hospitalization for more than 48 hours;
* Fracture (head, neck and spine);
* Having a neurological condition, other than the actual mTBI;
* Having a cognitive or behavioural impairment with participation in the study;
* Have had general anesthesia during the three-month period prior to the study;
* Having received physiotherapy tretament for the currwnt episode.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT03677661
Study Brief:
Protocol Section:
NCT03677661